Europe Cannabis Industry & Marijuana Business News


Number of Danish medical cannabis consumers plummets on CannTrust suspension

The number of patients accessing Denmark’s medical cannabis pilot program nearly halved in the third quarter of 2019, largely because of supply interruptions related to Canadian producer CannTrust’s regulatory misconduct. Unique consumers fell to 582 in the July-September period from 1,045 in the April-June quarter, according to Danish Health Authority data published last week. The […]

Read More

COVID-19 crisis effectively freezes European GMP cannabis inspections in Canada, elsewhere

European Union Good Manufacturing Practice (EU-GMP) certification audits involving cannabis facilities in Canada and elsewhere are screeching to a halt given the travel restrictions in place in most of the world because of the coronavirus pandemic. The discontinuation of the audits has meant that some overseas medical cannabis producers can’t receive the key certification to begin […]

Read More

Bedrocan CEO: European medical cannabis supply chain stable despite COVID-19 crisis

So far, the European market for medical cannabis has been spared the supply-chain disruptions inflicted by the coronavirus pandemic. That’s in stark contrast to the United States, where vape companies, packaging businesses and others have experienced shortages of cannabis-related hardware and supplies manufactured in China. For insights into the European market, Marijuana Business Daily international reporter […]

Read More

Deadline extended to apply for Germany’s cannabis distribution tender

The deadline to apply to be the distributor of domestically grown medical cannabis in Germany was extended from April 28 to May 26. The Federal Institute for Drugs and Medical Devices (BfArM) revealed the new deadline Tuesday. The document announcing the change did not provide a reason for the shift, but the current coronavirus pandemic […]

Read More

Insurance-covered cannabis in Germany sets fourth-quarter record, pushing 2019 total to 123 million euros

Insurance reimbursements for medical cannabis in Germany reached a new high during the October-December period, propelling total reimbursements last year up nearly 70% from 2018, according to new data from the German National Association of Statutory Health Insurance Funds (GKV-Spitzenverband). Despite some supply issues toward the end of 2019, reimbursements for medical marijuana reached 36.6 million euros ($40 […]

Read More

MJBizDaily postpones, cancels three cannabis trade events

Marijuana Business Daily has decided to postpone or cancel three upcoming cannabis industry trade events scheduled for the United States and overseas because of the coronavirus pandemic. Here are the details: MJBizDaily’s Investor Intelligence Symposium, scheduled for next month in New York, has been canceled. Attendees have been notified. In lieu of the cancellation, MJBizDaily will […]

Read More

Tell us if you think coronavirus will hit Germany’s MMJ supply

International medical marijuana supply chains appear stable for the time being despite the coronavirus pandemic, with shipments to Europe’s largest market, Germany, remaining uninterrupted. Despite more European countries going into full lockdown mode or closing borders because of the pandemic, disruption in the shipments of medical cannabis to Germany aren’t likely in the short term, according to industry experts. […]

Read More

Dutch cannabis ‘coffee shops’ to remain open amid coronavirus clampdown

The Netherlands will allow cannabis “coffee shops” to remain open under certain conditions, exempting the popular stores from measures forcing other shops to close their doors to fight the spread of coronavirus. The Dutch cabinet originally ordered the cannabis stores to suspend operations, along with restaurants, bars and nightclubs, but the government quickly reversed course after mayors warned that […]

Read More

Spannabis cannabis conference postponed amid coronavirus pandemic

Leading European marijuana business conference Spannabis Barcelona was postponed less than 48 hours before the planned start of the event. The conference was postponed for several months after local authorities suspended all gatherings larger than 1,000 people in an effort to contain the coronavirus. Spannabis is the latest cannabis-related conference to be closed or postponed in […]

Read More

More Canadian cannabis companies receive EU-GMP certifications

Two Canadian cannabis companies received EU-Good Manufacturing Practice (GMP) certification, an essential step to exporting medical marijuana to markets in the European Union. Brampton, Ontario-based producer Northern Green Canada received its EU-GMP certification March 4. On the same day, Eve & Co subsidiary Natural MedCo earned a certificate of EU-GMP compliance for its Strathroy, Ontario, […]

Read More